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The goal of the present study was to investigate the toxicity of biologically prepared small size of silver
nanoparticles in human lung epithelial adenocarcinoma cells A549. Herein, we describe a facile method for the
synthesis of silver nanoparticles by treating the supernatant from a culture of Escherichia coli with silver nitrate.
The formation of silver nanoparticles was characterized using various analytical techniques. The results from
UV-visible (UV-vis) spectroscopy and X-ray diffraction analysis show a characteristic strong resonance centered at
420 nm and a single crystalline nature, respectively. Fourier transform infrared spectroscopy confirmed the possible
bio-molecules responsible for the reduction of silver from silver nitrate into nanoparticles. The particle size analyzer
and transmission electron microscopy results suggest that silver nanoparticles are spherical in shape with an
average diameter of 15 nm. The results derived from in vitro studies showed a concentration-dependent decrease
in cell viability when A549 cells were exposed to silver nanoparticles. This decrease in cell viability corresponded to
increased leakage of lactate dehydrogenase (LDH), increased intracellular reactive oxygen species generation (ROS),
and decreased mitochondrial transmembrane potential (MTP). Furthermore, uptake and intracellular localization of
silver nanoparticles were observed and were accompanied by accumulation of autophagosomes and autolysosomes
in A549 cells. The results indicate that silver nanoparticles play a significant role in apoptosis. Interestingly, biologically
synthesized silver nanoparticles showed more potent cytotoxicity at the concentrations tested compared to that shown
by chemically synthesized silver nanoparticles. Therefore, our results demonstrated that human lung epithelial A549
cells could provide a valuable model to assess the cytotoxicity of silver nanoparticles.
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Recently, silver nanoparticles (AgNPs) show much inter-
est due to their unique physical, chemical, and biological
properties [1]. AgNPs have been widely used in personal
care products, food service, building materials, medical
appliances, and textiles owing to their unique features of
small size and potential antibacterial effect [1-3]. A bio-
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in any medium, provided the original work is pmicroorganisms, fungi or plant extracts has offered a re-
liable alternative to chemical and physical methods to
improve and control particle size. When compared to
physical and chemical methods, biological method is suit-
able to control particle size [4,5]. Biological methods have
several advantages such as low toxicity, cost-effectiveness,
physiological solubility, and stability [4,5].
The use of AgNPs has become more widespread for
sensing, catalysis, transport, and other applications in bio-
logical and medical sciences. This increased use has led to
more direct and indirect exposure in humans [2,6]. AgNPs
could induce multiple unpredictable and deleterious ef-
fects on human health and the environment due to their
increasing use. AgNPs can cause adverse effects in directlyOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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as the cardiovascular system or central nervous system
(CNS) upon systemic distribution. Nanoparticles can reach
the CNS via different routes [7,8]. Elder et al. [9] demon-
strated that manganese oxide nanoparticles could reach
the brain through the upper respiratory tract via the olfac-
tory bulb in rats. It has been shown that small nanoparti-
cles can translocate through and accumulate in an in vitro
blood brain barrier model composed of rat brain micro-
vessel vascular endothelial cells [10]. Trickler et al. [11]
demonstrated that small nanoparticles could induce in-
flammation and affect the integrity of a blood-brain bar-
rier model composed of primary rat brain microvessel
endothelial cells.
Toxicity of AgNPs depends on their size, concentra-
tion, and surface functionalization [12]. A recent report
suggested that the size of AgNPs is an important factor
for cytotoxicity, inflammation, and genotoxicity [13].
AgNPs have been shown to induce cytotoxicity via apop-
tosis and necrosis mechanisms in different cell lines
[14]. The possible exposure of the human body to the
nanomaterials occurs through inhalation, ingestion, in-
jection for therapeutic purposes, and through physical
contact at cuts or wounds on the skin [15]. These mul-
tiple potential routes of exposure indicate the need for
caution given the in vitro evidence of the toxicity of
nanoparticles. AgNPs have received attention because of
their potential toxicity at low concentrations [16]. The
toxicity of AgNPs has been investigated in various cell
types including BRL3A rat liver cells [17], PC-12 neuro-
endocrine cells [18], human alveolar epithelial cells [19],
and germ line stem cells [20]. AgNPs were more toxic
than NPs composed of less toxic materials such as titan-
ium or molybdenum [17].
Several studies reported that AgNP-mediated produc-
tion of reactive oxygen species (ROS) plays an important
role in cytotoxicity [15,20,21]. In vivo studies also sup-
port that AgNPs induced oxidative stress and increased
levels of ROS in the sera of AgNP-treated rats [22]. Oxida-
tive stress-related genes were upregulated in brain tissues
of AgNP-treated mice, including the caudate nucleus,
frontal cortex, and hippocampus [23]. Many studies have
suggested that AgNPs are responsible for biochemical and
molecular changes related to genotoxicity in cultured cells
such as DNA breakage [15,24]. Stevanovic et al. [25] re-
ported that (L-glutamic acid)-capped silver nanoparti-
cles and ascorbic acid encapsulated within freeze-dried
poly(lactide-co-glycolide) nanospheres were potentially
osteoinductive, and antioxidative, and had prolonged anti-
microbial properties. Several studies also suggest oxidative
stress-dependent antimicrobial activity of silver nanoparti-
cles in different types of pathogens [25-27]. Comfort et al.
[28] reported that AgNPs induce high quantities of ROS
generation and led to attenuated levels of Akt and Erkphosphorylation, which are important for the cell survival
in the human epithelial cell line A-431. AgNPs have been
more widely used in consumer and industrial products
than any other nanomaterial due their unique properties.
The most relevant occupational health risk from exposure
to AgNPs is inhalational exposure in industrial settings
[29]. Therefore, the first goal of this study was to design
and develop a simple, dependable, cost-effective, safe, and
nontoxic approach for the fabrication of AgNPs of uni-
form size. This was attempted by treating culture superna-
tants of Escherichia coli treated with silver nitrate. The
second goal was the characterization of these biologic-
ally prepared AgNPs (bio-AgNPs). Finally, the third goal
was to evaluate the potential toxicity of bio-AgNPs and
compare them with chemically prepared AgNPs (chem-
AgNPs) in A549 human lung epithelial adenocarcinoma
cells as an in vitro model system.
Methods
Chemicals
Penicillin-streptomycin solution, trypsin-EDTA solution,
Dulbecco's modified Eagle's medium (DMEM), and 1%
antibiotic-antimycotic solution were obtained from Life
Technologies GIBCO (Grand Island, NY, USA). Silver
nitrate, sodium dodecyl sulfate (SDS), and sodium citrate,
hydrazine hydrate solution, fetal bovine serum (FBS), In
Vitro Toxicology Assay Kit, TOX7, and 2′,7′-dichlorodi-
hydrofluorescein diacetate (H2-DCFDA) were purchased
from Sigma-Aldrich (St. Louis, MO, USA).
Synthesis of bio-AgNPs and chem-AgNPs
Synthesis of bio-AgNPs was carried out according to a
previously describe method [4]. Briefly, E. coli bacteria
were grown in Luria Bertani (LB) broth without NaCl.
The flasks were incubated for 21 h in a shaker set at 200
rpm and 37°C. After the incubation period, the culture
was centrifuged at 10,000 rpm and the supernatant was
used for the synthesis of bio-AgNPs. To produce bio-
AgNPs, the culture supernatant treated with 5 mM silver
nitrate (AgNO3) was incubated for 5 h at 60°C at pH
8.0. The synthesis of bio-AgNPs was monitored by visual
inspection of the test tubes for a color change in the cul-
ture medium from a clear, light yellow to brown. For
comparison with bio-AgNPs, we used a citrate-mediated
synthesis of silver nanoparticles to generate chem-AgNPs.
The synthesis of chem-AgNPs was performed according
to a previously described method [30].
Characterization of bio-AgNPs
Characterization of bio-AgNPs particles was carried
out according to methods described previously [4]. The
bio-AgNPs were characterized by UV-visible (UV-vis)
spectroscopy. UV-vis spectra were obtained using a
Biochrom WPA Biowave II UV/Visible Spectrophotometer
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Zetasizer Nano ZS90 (Malvern Instruments, Limited, Mal-
vern, UK). X-ray diffraction (XRD) analyses were carried
out on an X-ray diffractometer (Bruker D8 DISCOVER,
Bruker AXS GmBH, Karlsruhe, Germany). The high-
resolution XRD patterns were measured at 3 Kw with Cu
target using a scintillation counter. (λ = 1.5406 Å) at 40 kV
and 40 mA were recorded in the range of 2θ = 5° to 80°.
Further characterization of changes in the surface and
surface composition was performed by Fourier transform
infrared spectroscopy (FT-IR) (PerkinElmer Spectroscopy
GX, PerkinElmer, Waltham, MA, USA). Transmission
electron microscopy (TEM), using a JEM-1200EX micro-
scope (JEOL Ltd., Akishima-shi, Japan) was performed to
determine the size and morphology of bio-AgNPs. TEM
images of bio-AgNPs were obtained at an accelerating
voltage of 300 kV.Cell Culture and exposure to AgNPs
A549 human lung epithelial adenocarcinoma cells were
cultured in DMEM medium supplemented with 10%
FBS and 100 U/mL penicillin-streptomycin at 5% CO2
and 37°C. The medium was replaced three times per
week, and the cells were passaged at subconfluency. At
75% confluence, cells were harvested by using 0.25%
trypsin and were sub-cultured into 75-cm2 flasks, 6-well
plates, and 96-well plates based on the type of experi-
ment to be conducted. Cells were allowed to attach the
surface for 24 h prior to treatment. A 100 μL aliquot of
the cells prepared at a density of 1 × 105 cells/mL was
plated in each well of 96-well plates. After culture for 24
h, the culture medium was replaced with medium con-
taining bio-AgNPs prepared at specific concentrations (0
to 50 μg/mL) and chem-AgNPs (0 to 100 μg/mL). After
incubation for an additional 24 h, the cells were col-
lected and analyzed for viability, lactate dehydrogenase
(LDH) release, and ROS generation according to the
methods described earlier [31]. Cells that were not ex-
posed to AgNPs served as controls.Cell viability (MTT) assay
The cell viability assay was measured using MTT assay.
Briefly, A549 human lung epithelial adenocarcinoma
cells were plated onto 96-well flat bottom culture plates
with various concentrations of AgNPs. All cultures were
incubated for 24 h at 37°C in a humidified incubator.
After 24 h of incubation, 10 μL of MTT (5 mg/mL in
phosphate-buffered saline (PBS) was added to each well,
and the plate was incubated for a further 4 h at 37°C.
The resulting formazan (product of MTT reduction)
was dissolved in 100 μL of DMSO with gentle shaking at
37°C, and absorbance was measured at 595 nm with an
ELISA reader.Membrane integrity (LDH release) assay
Cell membrane integrity of A549 human lung epithelial
adenocarcinoma cells was evaluated according to the
manufacturer's instructions. Briefly, cells were exposed
to different concentrations of AgNPs for 24 h and then
100 μL per well of each cell-free supernatant was trans-
ferred in triplicate into wells in a 96-well plate, then 100
μL of LDH-assay reaction mixture was added to each
well. After 3 h incubation under standard conditions,
the optical density was measured at a wavelength of 490
nm using a microplate reader.
Reactive oxygen species (H2-DCFH-DA) assay
A549 human lung epithelial adenocarcinoma cells
were cultured in minimum essential medium (Hyclone
Laboratories, Logan, UT, USA) containing 10 μM H2-
DCFDA in a humidified incubator at 37°C for 30 min.
Cells were washed in PBS (pH 7.4) and lysed in lysis buffer
(25 mM HEPES [pH 7.4], 100 mM NaCl, 1 mM EDTA, 5
mMMgCl2, and 0.1 mM DTT supplemented with a prote-
ase inhibitor cocktail). Cells were cultured on coverslips in
a 4-well plate. Cells were incubated in DMEM containing
10 μM H2-DCFDA at 37°C for 30 min. Cells were washed
in PBS, mounted with Vectashield fluorescent medium
(Burlingame, CA, USA), and viewed with a fluorescence
microscope.
Mitochondrial transmembrane potential (JC-1) assay
The change in mitochondrial transmembrane potential
(MTP) was determined using the cationic fluorescent indi-
cator, JC-1 (Molecular Probes Eugene, OR, USA). In intact
mitochondria with a normal MTP, JC-1 aggregates have a
red fluorescence, which was measured with an excitation
wavelength of 488 nm and an emission wavelength of 583
nm using a GeminiEM fluorescence multiplate reader
(Molecular Devices, Sunnyvale, CA, USA). By contrast,
JC-1 monomers in the cytoplasm have a green fluores-
cence, which was measured with an excitation wavelength
of 488 nm and an emission wavelength of 525 nm. The
presence of JC-1 monomers was indicative of a low MTP.
A549 human lung epithelial adenocarcinoma cells were
cultured in DMEM containing 10 μM JC-1 in a humidified
incubator at 37°C for 15 min. Cells were washed with PBS
and then transferred to a transparent 96-well plate. JC-1
monomer-positive cell populations were determined with
a FACSCalibur instrument. Cells were cultured on cover-
slips housed in a 4-well plate, incubated in DMEM con-
taining 10 μM JC-1 at 37°C for 15 min, and then washed
with PBS. Cells were mounted with Vectashield fluorescent
medium and viewed with a fluorescence microscope.
Cellular uptake of AgNPs
To study the cellular uptake of AgNPs, cells were treated
with AgNPs for 48 h, harvested, and fixed with a mixture
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PBS for 8 h at pH 7.2. After fixation, the cells were incu-
bated with 1% osmium tetroxide in PBS for 2 h. The fixed
cells were dehydrated in ascending concentrations of etha-
nol (70%, 80%, 90%, 95%, and 100%) and embedded in
EMbed 812 resins (EMS, Warrington, PA, USA) via pro-
pylene oxide. Ultrathin sections were obtained using an
ultramicrotome (Leica, IL, USA) and were double stained
with uranyl acetate and lead citrate. The stained sections
on the grids were then examined with a H7000 TEM
(Hitachi, Chiyoda-ku, Japan) at 80 kV.
Results and discussion
Synthesis and characterization of biologically synthesized
AgNPs
The aim of this experiment was to produce smaller size
of AgNPs using the culture supernatant of E. coli and to
understand the effect of toxicity in human lung epithelial
A549 cells of the AgNPs. In order to control the particle
size of bio-AgNPs, 5 mM AgNO3 was added to the cul-
ture supernatant and incubated for 5 h at 60°C at pH 8.0
[4,32]. Synthesis was confirmed by visual observation of
the culture supernatant. The supernatant showed a color
change from pale yellow to brown. No color change
was observed during incubation of culture supernatant
without AgNO3 or in media with AgNO3 solution alone
(Figure 1 inset). The appearance of a yellowish brown
color in AgNO3-treated culture supernatant suggested the
formation of AgNPs [4,32,33].Figure 1 Synthesis and characterization of bio-AgNPs using culture su
of silver nitrate (AgNO3) after exposure to 5 h (1), AgNO3 with the extracell
E. coli (3). The color of the solution turned from pale yellow to brown after
The absorption spectrum of AgNPs synthesized by E. coli culture supernata
a band is assigned to surface plasmon resonance of the particles.Prior to the study of the cytotoxic effect of AgNPs,
characterization of bio-AgNPs was performed according
to methods previously described [4]. Bio-AgNPs were
synthesized using E. coli culture supernatant. The syn-
thesized bio-AgNPs were characterized by UV-visible
spectroscopy, which has been shown to be a valuable
tool for the analysis of nanoparticles [4,34,35]. In the
UV-visible spectrum, a strong, broad peak at about 420
nm was observed for bio-AgNPs (Figure 1). The specific
and characteristic features of this peak, assigned to a
surface plasmon, has been well documented for various
metal nanoparticles with sizes ranging from 2 to 100 nm
[4,34,35]. In this study, we synthesized bio-AgNPs with
an average a diameter of 15 nm.
Next, the cytotoxic effects of bio-AgNPs were evalu-
ated using an in vitro model. Earlier studies reported
that synthesis of bio-AgNPs by treating the culture
supernatant of E. coli [4] and Bacillus licheniformis [33]
with AgNO3 produced bio-AgNPs with an average diam-
eter of 50 nm. These bio-AgNPs have been used for both
in vitro and in vivo studies [36-38]. AgNPs with a size of
20 nm or less could enter the cell without significant
endocytosis and are distributed within the cytoplasm
[39]. Cellular uptake was greater in AgNPs 20 nm or less
than with AgNPs above 100 nm in human glioma U251
cells [40]. Park et al. [13] studied the effects of various
sizes of AgNPs (20, 80, 113 nm) by testing them in
in vitro assays such as cytotoxicity, inflammation, geno-
toxicity, and developmental toxicity. They concludedpernatant from E. coli. The inset shows tubes containing samples
ular culture supernatant of E. coli (2), and AgNO3 plus supernatant of
5 h of incubation, indicating the formation of silver nanoparticles.
nt exhibited a strong broad peak at 420 nm and observation of such
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nm were more toxic than larger nanoparticles.
XRD analysis of AgNPs
Further characterization was carried out to confirm the
crystalline nature of the particles, and a representative
XRD pattern of bio-AgNPs is shown in Figure 2. The
XRD pattern shows four intense peaks in the whole
spectrum of 2θ values ranging from 20 to 80. A compari-
son of our XRD spectrum with the standard confirmed
that the silver particles formed in our experiments were
nanocrystals, as evidenced by the peaks at 2θ values of
23.6°, 29.5°, 33.7°, and 46.7°, corresponding to 111, 200,
220, and 311 lattice planes for silver, respectively. XRD
data confirm the crystallization of AgNPs exhibited 2θ
values corresponding to the previously reported values for
silver nanocrystals prepared from the E. coli supernatant
[4]. Thus, the XRD pattern confirms the crystalline planes
of the face-centered cubic (fcc)-structured AgNPs, sug-
gesting the crystalline nature of these AgNPs [4].
FTIR analysis of AgNPs
The FTIR spectrum was recorded for the freeze-dried
powder of bio-AgNPs. The amide linkages between amino
acid residues in proteins give rise to the well-known signa-
tures in the infrared region of the electromagnetic
spectrum. The bands between 3,000 and 4,000 cm−1 were
assigned to the stretching vibrations of primary and
secondary amines, respectively, while their corresponding
bending vibrations were seen at 1,383 and 1,636 cm−1, re-
spectively (Figure 3). The overall spectrum confirms the
presence of protein in samples of bio-AgNPs. EarlierFigure 2 XRD pattern of AgNPs. A representative X-ray diffraction (XRD)
natant of E. coli with 5 mM of silver nitrate (AgNO3) for 5 h at 50°C. The XR
ranging from 20 to 70. The intense peaks were observed at 2θ values of 23.6°
silver, respectively.studies suggested that proteins can bind to nanoparticles
either through their free amine groups or cysteine residues
[41]. FTIR provides evidence for the presence of proteins
as possible biomolecules responsible for the reduction and
capping agent, which helps in increasing the stability of
the bio-AgNPs [41].
Size and morphology analysis of AgNPs by TEM
TEM is one of the most valuable tools to directly analyze
structural information of the nanoparticles. TEM was used
to obtain essential information on primary nanoparticle
size and morphology [42]. TEM micrographs of the bio-
AgNPs revealed distinct, uniformly spherical shapes that
were well separated from each other. The average particle
size was estimated from measuring more than 200 parti-
cles from TEM images and showed particle sizes between
11 and 28 nm with an average size of 20 nm (Figure 4).
Several labs used various microorganisms for synthesis
of bio-AgNPs including Klebsiella pneumonia and E. coli
with an average AgNP size of 52.5 nm and 50 nm, re-
spectively [4,43]. In case of gram-positive bacteria such
as B. licheniformis [33], Bacillus thuringiensis [44], and
Ganoderma japonicum [45] produced an average size of
50, 15, and 5 nm, respectively. Earlier studies showed
that bio-AgNPs synthesized with the supernatant form
E. coli and B. licheniformis were about 50 nm [4,33].
Interestingly, E. coli strain can produce lower sizes of
nanoparticles under optimized conditions. Several stud-
ies have reported the synthesis of AgNPs using fungi
such as spent mushrooms [46], Pleurotus florida [47],
Volvariella volvacea [48], Ganoderma lucidum [49], and
Ganoderma neo japonicum [45]. These AgNPs hadpattern of silver nanoparticles formed after reaction of culture super-
D pattern shows four intense peaks in the whole spectrum of 2θ values
, 29.5°, 33.7°, and 46.7°, corresponding to 111, 200, 220, and 311 planes for
Figure 3 FT-IR spectrum of biologically synthesized silver nanoparticles.
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though various microorganisms produce various sizes,
the AgNP size can be adjusted through optimization of
various parameters such as concentration of AgNO3,
temperature, and pH [4].
Size distribution analysis by dynamic light scattering
TEM images are captured under high vacuum condi-
tions with a dry sample; therefore, additional experiments
were carried out to determine particle size in aqueous or
physiological solutions using dynamic light scattering
(DLS). The characterization of nanoparticles in solution is
essential before assessing the in vitro toxicity [42]. Particle
size, size distribution, particle morphology, particleA
Figure 4 Size and morphology of AgNPs analysis by TEM. (A). Several
silver nanoparticles (AgNPs). (B). Particle size distributions from transmission
diameter was 15 nm.composition, surface area, surface chemistry, and particle
reactivity in solution are important factors in assessing
nanoparticle toxicity [42]. Powers et al. [50] proposed DLS
as a useful technique to evaluate particle size and size dis-
tribution of nanomaterials in solution. In the present
study, DLS was used, in conjunction with TEM, to evalu-
ate the size distribution of AgNPs. The bio-AgNPs and
chem-AgNPs showed with an average size of 20 and
35 nm, respectively, which is slightly larger than those
observed in TEM, which may be due to the influence
of Brownian motion. Murdock et al. [42] demonstrated
that many metal and metal oxide nanomaterials agglomer-
ate in solution and that, depending upon the solution,
particle agglomeration is either stimulated or mitigated.B
fields were photographed and used to determine the diameter of
electron microscopy images. The average range of observed
Figure 5 Size distribution analysis by dynamic light scattering (DLS). Biologically synthesized silver nanoparticles (bio-AgNPs) and chemically
synthesized silver nanoparticles (chem-AgNPs) were dispersed in deionized water and DMEM media with and without serum. The particles were
mixed thoroughly via sonication and vortexing, and samples were measured at 25 μg/ml.
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ous solutions such as water, DMEM media, and DMEM
with 10% FBS using dynamic light scattering assay. It was
found that the average size of bio-AgNPs was 20 ± 5.0,
65 ± 16.0, and 35 ± 8.0 nm in water, DMEM media, and
DMEM with 10% serum, respectively. The average size of
chem-AgNPs was 35 ± 10.0, 125 ± 20.0, and 75 ± 15.0 nm
in water, DMEM media, and DMEM with 10% FBS,
respectively (Figure 5). The results suggest that the bio-
AgNPs particles dissolved in DMEM media were slightly
different from AgNPs dissolved in water. Similarly,
DMEM media with 10% FBS showed slight variation
in sizes.
DLS results for particle size in solution indicated the
chem-AgNPs tended to form agglomerates of greaterFigure 6 Effect of AgNPs on cell viability of A549 human lung epithe
(AgNPs) at several concentrations for 24 h and cytotoxicity was determined
three separate experiments each of which contained three replicates. Treat
group by the Student's t test (p < 0.05).size than bio-AgNPs when dispersed in either water or
cell culture media. The chem-AgNPs particles ranged
from 35 nm in water to 125 and 75 nm in DMEM media
without and with serum, respectively. Although, both
AgNPs were highly agglomerated in DMEM media with-
out serum, the chem-AgNPs agglomeration was signifi-
cantly greater than bio-AgNPs. This may be due to the
type of capping agents used for the synthesis of nanopar-
ticles. Murdock et al. [42] found that Ag-based particles
exhibited a similar pattern by agglomerating at nearly
the same size when dispersed in either water or media
with serum. They also observed that polysaccharide-coated
silver nanoparticles with an average size of 80 nm by TEM
showed an increase from 250 nm in water to 1,230 nm in
RPMI-1640 media with serum.lial adenocarcinoma cells. Cells were treated with silver nanoparticles
by the MTT method. The results are expressed as the mean ± SD of
ed groups showed statistically significant differences from the control
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These experiments were intended to investigate the cyto-
toxic effects of bio-AgNPs and chem-AgNPs in lung epi-
thelial adenocarcinoma cells as an in vitro model. Viability
assays are used to assess the cellular responses of any toxi-
cant that influences metabolic activity [15]. In order to see
the effect of AgNPs on cell viability, we used mitochondria
function as a cell viability marker in A549 human lung epi-
thelial adenocarcinoma. Incubating bio-AgNPs or chem-
AgNPs with medium only and checking the absorption
served as the control. These studies showed that the
presence of culture media and all the bio-AgNPs/chem-
AgNPs did not interfere with the MTTassay.
Cell viability studies with bio-AgNPs were carried out
over the concentration range of 0 to 50 μg/ml. The re-
sults suggested that bio-AgNPs at 25 μg/ml decreased
the viability of A549 cells to 50% of the control level, so
this was determined to be the IC50. Exposures to higher
concentrations resulted in increased toxicity to the cells
(Figure 6). In case of chem-AgNPs, 0 to 50 μg/ml had
no toxic effect in A549 cells. We tested additional con-
centrations between 50 to 100 μg/ml. The results sug-
gested that chem-AgNPs at 70 μg/ml decreased the
viability of A549 cells to 50% of the initial level, and this
was determined by the IC50 (Figure 6).
The MTT cell viability assay demonstrated that both
AgNPs produced concentration-dependent cell death.
However, chem-AgNPs were less potent in producing
cytotoxicity when compared to bio-AgNPs. The less po-
tent cytotoxic effect of chem-AgNPs may be due to
higher agglomeration. Uncontrolled agglomeration alters
the size and shape of nanoparticles, which greatly influ-
ences the cell-particle interactions. Large agglomerations
of particles can significantly hinder the effects of individ-
ual particle size and shape on toxicity [17]. Zook et al.
[51] demonstrated that the large agglomerates of silver
nanoparticles caused significantly less hemolytic toxicity
than small agglomerates.
Different cytotoxic effects of AgNPs have been reported
in various cell types, indicating that AgNPs affected cell
survival by disturbing the mitochondrial structure and
metabolism [15,52,53]. Our results are in agreement with
previous studies about smaller sized AgNPs having been
found to be more toxic than larger ones [14,40,44,54].
Mukherjee et al. [55] reported that no inhibition of cell
proliferation was observed when A549 cells were incu-
bated with chem-AgNPs (3 and 30 μM).
Gnanadhas et al. [56] demonstrated that the potency
of AgNPs was based on the type of capping agent used.
Several other studies also reported that capping agents
stabilized the AgNPs by decreasing aggregation of the par-
ticles and providing protection from temperature and light
[57,58]. Enhanced toxicity was observed when AgNPs
were coated with different capping agents. Murdock et al.[42] found that the addition of serum to cell culture media
had a significant effect on particle toxicity possibly due to
changes in agglomeration or surface chemistry. This study
was in agreement with earlier reports that suggested that
the toxicity of nanoparticles depends on physicochemical
properties such as size, shape, surface coating, surface
charge, surface chemistry, solubility, and chemical com-
position [59].
AgNPs induced LDH leakage
LDH is an enzyme widely present in cytosol that con-
verts lactate to pyruvate. Release of LDH from cells into
the surrounding medium is a typical marker for cell
death. When plasma membrane integrity is disrupted,
LDH leaks into the media and its extracellular levels in-
crease indicating cytotoxicity by nanoparticles [54] or
other substances. We examined whether AgNPs led to
LDH leakage into the medium. In order to determine
the effect of AgNPs on LDH leakage, the cells were
treated with various concentrations of AgNPs and then
LDH leakage was measured [31,54]. Cells treated with
bio-AgNPs showed significantly higher LDH values in
the medium than chem-AgNPs indicate that bio-AgNPs
were more potent in producing cytotoxicity in A549
cells (Figure 7). Chem-AgNP-treated cells showed sig-
nificantly higher LDH release at high concentrations
compared to untreated cells (Figure 7).
In this study, the LDH activity in the medium was signifi-
cantly higher for cells treated with bio-AgNPs, especially at
higher concentrations (over 20 μg/mL). Conversely, chem-
AgNPs showed toxicity only at higher concentrations (over
60 μg/mL). These findings demonstrated that AgNPs
could produce cell death. Miura and Shinohara [60]
demonstrated potential cytotoxicity and increased expres-
sion levels of stress genes, ho-1 and mt-2A, at higher
concentrations of AgNPs in Hela cells. Kim et al. [61]
reported size and concentration-dependent cellular tox-
icity of AgNPs in MC3T3-E1 and PC12 cells. Their studies
included assessments of cell viability, reactive oxygen spe-
cies generation, LDH release, ultrastructural changes in
cell morphology, and upregulation of stress-related genes
(ho-1 and MMP-3). We found that an IC50 concentration
of 25.0 μg/mL for bio-AgNPs and 70.0 μg/mL for chem-
AgNPs was significant on cell viability. Therefore, these
concentrations were used for further studies.
AgNPs induced generation of ROS
ROS generation is a marker for oxidative stress. Produc-
tion of ROS causes oxidative damage to cellular compo-
nents, eventually leading to cell death. Oxidative stress is
one of the key mechanisms of AgNPs toxicity and can
promote apoptosis in response to a variety of signals and
pathophysiological situations [44,54,62,63]. In this assay,
we have used DCFH-DA to evaluate ROS production.
Figure 7 Effect of AgNPs on LDH release from A549 human lung epithelial adenocarcinoma cells. Lactate dehydrogenase (LDH) was
measured by changes in optical density due to NAD+ reduction monitored at 490 nm, as described in the ‘Methods’ section. The results are
expressed as the mean ± SD of three separate experiments each of which contained three replicates. Treated groups showed statistically
significant differences from the control group by the Student's t test (p < 0.05).
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http://www.nanoscalereslett.com/content/9/1/459Figure 8 shows the fluorescence images of untreated
A549 cells and cells treated with AgNPs and harvested
at different times points. The control sample showed no
green fluorescence indicating a lack of H2O2 formation,
whereas bio-AgNP-treated cells showed bright green
fluorescence (Figure 8, upper panel). Maximum green
fluorescence intensity was observed at 12 and 24 h in
A549 cells treated with bio-AgNPs. As shown in Figure 8
(lower panel), untreated A549 cells show much weaker
green fluorescence than chem-AgNP-treated cells. More
intense green fluorescence was observed with increasing
time of incubation. Maximum green fluorescenceFigure 8 ROS generation in AgNP-treated A549 human lung epithelia
silver nanoparticles (AgNPs) (0) and cells treated with biologically synthesiz
(chem-AgNPs) (70 μg/ml) and incubated at different time points. Both bio-
inside the A549 cells.intensity was observed in the A549 cells treated with
bio-AgNPs (25 μg/ml) which exceed the fluorescence
produced by chem-AgNPs (70 μg/ml).
A similar trend was seen in the formation of hydrogen
peroxide and superoxide anion in the cancer cells
treated with bio-AgNPs prepared using Olax scandens
leaf extract [55]. Several studies have suggested that the
antitumor or antiproliferation activity of silver and gold
nanoparticles to cancer cells was observed due to forma-
tion of ROS inside the cells [45,64-66].
The results of the current study suggested that cells
treated with AgNPs showed concentration-dependentl adenocarcinoma cells. Fluorescence images of A549 cells without
ed AgNPs (bio-AgNPs) (25 μg/ml) and chemically synthesized AgNPs
AgNPs and chem-AgNPs support the formation of hydrogen peroxide
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sible for cellular damage and eventually lead to cell death.
These results are in agreement with previously published
results [15,63]. AgNPs treatment generated elevated
intracellular ROS levels and abolished antioxidants like re-
duced glutathione or antioxidant enzymes, such as gluta-
thione peroxidase and superoxide dismutase, leading to
the formation of DNA adducts [15,63]. Intracellular ROS
were reported to be a crucial indicator of various toxic ef-
fects from NPs [53]. Recent studies have reported AgNPs-
mediated generation of ROS in different cell types which
induced cell death [23,62,67]. Rahman et al. [23] reported
that 25 nm sized AgNPs produced a significant in-
crease in ROS production in vitro and in vivo. The induc-
tion of apoptosis by exposure to AgNPs was mediated
by oxidative stress in fibroblasts, muscle, and colon
cells [62,67]. Recently, Kim et al. [61] showed the pro-
duction of ROS was detected in both the MC3T3-E1 and
PC12 cell lines in a particle size- and concentration-
dependent manner.
Modulation of MTP by AgNPs
Decreased MTP can be an early event in apoptosis.
Decreased MTP, as detected by JC-1, was used to investi-
gate whether AgNPs could elicit MTP disruption or not.
In general, mitochondria-mediated apoptosis results
when mitochondria undergo two major changes. The first
change is the permeabilization of the outer mitochondrialFigure 9 AgNPs modulates mitochondrial transmembrane potential. C
determined using the cationic fluorescent indicator, JC-1. Fluorescence
and cells treated with biologically synthesized AgNPs (bio-AgNPs) (25 μ
The changes of mitochondrial membrane potential by AgNPs were obt
J-aggregates in healthy A549 cells with high MTP, whereas A549 cells
showing green fluorescence.membrane, and the second is the loss of the electrochem-
ical gradient [68]. The permeabilization of the outer mem-
brane is tightly regulated by a member of the Bcl-2 family.
Membrane depolarization is mediated by the mito-
chondrial permeability transition pore. Prolonged mito-
chondrial permeability transition pore opening leads to a
compromised outer mitochondrial membrane [68,69]. As
shown in Figure 9, the control cells differently exhibited
red fluorescence, indicating that a high fraction of
mitochondria were in the energized state [70]. However, de-
creases in mitochondrial energy transduction were ob-
served following treatment of AgNPs for 1 h, illustrated by
disappearance of red fluorescence and emergence of green
fluorescence. Although both bio-AgNPs and chem-AgNPs
could cause MTP collapse, bio-AgNPs were more potent at
producing depolarization than chem-AgNPs. These results
suggest that AgNPs could induce apoptosis through a
mitochondria-mediated apoptosis pathway. A similar obser-
vation was made in RAW264.7 cells with the tertbutylhy-
droperoxide treatment-enhanced mitochondria-mediated
apoptosis through failure of MTP [70].
Cellular uptake of AgNPs induces accumulation of
autophagosomes and autolysosomes
Oxidative stress plays an important role in various patho-
logical conditions including some neurodegenerative dis-
eases and several cardiac diseases which have been related
to the process of autophagy [71,72]. Accumulation ofhanges in mitochondrial transmembrane potential (MTP) was
images of control A549 cells (without silver nanoparticles (AgNPs))
g/ml) and chemically synthesized AgNPs (chem-AgNPs) (70 μg/ml).
ained using fluorescence microscopy. JC-1 formed red-fluorescent
exposed to AgNPs had low MTP and, JC-1 existed as a monomer,
Figure 10 Intracellular localization of AgNPs and accumulation of autophagosomes and autolysosomes. A549 cells were treated with
silver nanoparticles (AgNPs) for 24 h and then processed for transmission electron microscopy (TEM) sections. TEM images of ultramicrotome
slices of A549 cells without AgNPs (A), internalization of biologically synthesized AgNPs (bio-AgNPs) (B), and internalization of chemically
synthesized AgNPs (chem-AgNPs) within the cells (C). Bio-AgNPs induces accumulation of autophagosomes (black arrow) and autolysosomes
(white arrow) in cells treated with bio-AgNPs for 24 h (D). Autolysosomes and vesicular structures consistent with autophagy were detected in
cells treated with bio-AgNPs (E) and chem-AgNPs (F).
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response, which induces various cell defense mechanisms
or programmed cell death [73-75]. Autophagy may pro-
tect cells against cell death under oxidative stress, due to
higher likelihood that oxidized proteins will be taken up
by autophagosomes and subsequently degraded by lyso-
somes. This process contributes to the efficient removal of
oxidized proteins and reduces further oxidative damage
[73-76]. Oxidant stress has been implicated in triggering
autophagy by certain agents such as hydrogen peroxide
(H2O2) and 2-methoxyestradiol (2-ME) [73-76].
Cellular uptake studies were carried out to determine
the fate of AgNPs in terms of agglomeration, internaliza-
tion, cell attachment, and accumulation in autophago-
somes and autolysosomes. The cells were exposed to the
bio-AgNP dose (25 μg/ml) and chem-AgNPs (70 μg/ml)
for 24 h, fixed, and prepared for TEM analysis. To avoid
misinterpretation due to staining artifacts, the cells
were treated with uranyl acetate without lead citrate.
The A549 controls appeared normal, with prominentnucleus, nucleolus, and mitochondria (Figure 10A). Bio-
AgNP- and chem-AgNPs-treated cells are shown in
Figure 10B,C. After 24 h, AgNPs were internalized and
cellular morphological changes suggest that autophagy
had occurred in the treated cells. AgNPs were localized
within membrane-bound cytoplasmic vacuoles and in en-
larged lysosomes. Cells exposed to AgNPs exhibit a typical
autophagosomes (blue arrow) and autolysosmes (red arrow)
with double membranes and enclosed cellular con-
tents (Figure 10D). In addition, when compared to the
unexposed control cells, the treated cells showed many
multivesicular and membrane-rich autophagosomes in
close proximity to each other indicating that AgNPs could
induce autophagosome formation at the ultrastruc-
tural level. Further, the TEM examination revealed
phagophore structures, double-membrane autophago-
somes with engulfed damaged organelles (blue arrow),
and autolysosomes (red arrow) with an enlarged vacu-
oles containing large amounts of cellular debris were all
present in both bio-AgNPs and chem-AgNPs treated cells
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increase in cytoplasmic vacuoles in cells exposed to
PM2.5 exposure, along with the formation of LC3 puncta
and accumulation of LC3-II, the only protein markers
reliably associated with completed autophagosomes [77].
Several studies reported that H2O2 triggered autophagy
or apoptosis in U87 cells, HeLa cells, and M14 cells
[75,78,79]. Our studies suggest that the accumulation of
autophagosomes and enlarged lysomes/autolysosomes may
be due to the oxidative stress induced by AgNPs. These
preliminary data also suggest that AgNPs may interrupt
the autophagic pathway and may have important im-
plications in biomedical applications of nanoparticles.
Although these studies have indicated that AgNPs could
induce autophagy, further investigation is needed into the
detail mechanism of oxidative stress mediated autophagy.
Conclusions
Silver nanoparticles (AgNPs) have been used in various
medical and biomedical applications such as antibacter-
ial, antiproliferative, anticancer, antiangiogenic, and anti-
inflammatory. Therefore, this study was designed to
evaluate the potential toxicity of bio-AgNPs in human
lung epithelial adenocarcinoma cell line (A549). Initially,
the biologically synthesized AgNPs were characterized
using various analytical procedures using UV-vis spec-
trometry, XRD, FTIR, TEM, and DLS. The bio-AgNPs
were homogenous in shape, and the average size was 15
nm. Cellular toxicity was determined using various cellu-
lar assays such as cell viability, leakage of LDH, ROS
generation, and mitochondrial membrane potential. ROS
generation was significantly increased; there was a strong
correlation between the levels of ROS and cell viability.
The results suggested that the toxicity of AgNPs was
concentration-dependent and bio-AgNPs were significantly
more toxic at lower concentrations than chem-AgNPs.
Cellular uptake studies revealed that AgNPs entered the
cell and eventually induced oxidative stress, and oxidative
stress could play a role in the formation of autosomes and
autolysosomes in A549 cells. Altogether, our results dem-
onstrated that cell death and autophagy in A549 cells could
be mediated through ROS generation induced by AgNPs.
These results also suggest that regulation of ROS gener-
ation and autophagy might be a potential strategy for treat-
ment of lung cancer.
Competing interests
The authors declare they have no competing interests.
Authors' contributions
JWH and SG performed synthesis of silver nanoparticle (AgNP), design, cell
transfection, western blotting, and reverse transcription-polymerase chain
reaction (RT-PCR) analysis. JKJ, YJC, and DNK carried out the effect of AgNPs
on cell viability and LDH release and performed the statistical analysis.
SG, JKP, and JHK wrote the manuscript. J-H Kim supervised the project.
All authors discussed the results and commented on the manuscript. All
authors read and approved the final manuscript.Acknowledgements
This work was supported by the KU-Research Professor Program of Konkuk
University. Dr Sangiliyandi Gurunathan was supported by a Konkuk University
KU-Full-time Professorship. This work was also supported by the Next-Generation
Biogreen 21 Program (Project No. PJ009107) from the Rural Development
Administration (RDA), Republic of Korea.
Author details
1Department of Animal Biotechnology, Konkuk University, 1 Hwayang-Dong,
Gwangin-gu, Seoul 143-701, Korea. 2GS Institute of Bio and Nanotechnology,
Coimbatore, Tamilnadu 641024, India. 3Animal Biotechnology Division,
National Institute of Animal Science, Suwon 441-350, Korea.
Received: 1 July 2014 Accepted: 18 August 2014
Published: 2 September 2014
References
1. Chen X, Schluesener HJ: Nanosilver: a nanoproduct in medical application.
Toxicol Lett 2008, 176(1):1–12.
2. Park EJ, Yi J, Kim Y, Choi K, Park K: Silver nanoparticles induce cytotoxicity
by a Trojan-horse type mechanism. Toxicol In Vitro 2010, 24(3):872–878.
3. Arora S, Rajwade JM, Paknikar KM: Nanotoxicology and in vitro studies:
the need of the hour. Toxicol Appl Pharmacol 2012, 258(2):151–165.
4. Gurunathan S, Kalishwaralal K, Vaidyanathan R, Venkataraman D, Pandian SR,
Muniyandi J, Hariharan N, Eom SH: Biosynthesis, purification and
characterization of silver nanoparticles using Escherichia coli.
Colloids Surf B: Biointerfaces 2009, 74(1):328–335.
5. Li XQ, Xu HZ, Chen ZS, Chen GF: Biosynthesis of nanoparticles by
microorganisms and their applications. J Nanomater 2011, 2011:270974.
6. Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel.
Science 2006, 311(5761):622–627.
7. Kreyling WG, Semmler-Behnke M, Moller W: Health implications of
nanoparticles. J Nanoparticle Res 2006, 8(5):543–562.
8. Oberdorster G, Elder A, Rinderknecht A: Nanoparticles and the brain: cause
for concern? J Nanosci Nanotechnol 2009, 9(8):4996–5007.
9. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R,
Mayanard A, Ito Y, Finkelstein J, Oberdorster G: Translocation of inhaled
ultrafine manganese oxide particles to the central nervous system.
Environ Health Perspect 2006, 114(8):1172–1178.
10. Tang JL, Xiong L, Wang S, Wang J, Liu L, Li J, Yuan F, Xi T: Distribution,
translocation and accumulation of silver nanoparticles in rats. J Nanosci
Nanotechnol 2009, 9(8):4924–4932.
11. Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD,
Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr, Hussain SM, Ali SF: Silver
nanoparticle induced blood–brain barrier inflammation and increased
permeability in primary rat brain microvessel endothelial cells. Toxicol Sci
2010, 118(1):160–170.
12. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M: Uptake and
intracellular distribution of silver nanoparticles in human mesenchymal
stem cells. Acta Biomater 2011, 7(1):347–354.
13. Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW,
Briedé JJ, van Loveren H, de Jong WH: The effect of particle size on the
cytotoxicity, inflammation, developmental toxicity and genotoxicity of
silver nanoparticles. Biomaterials 2011, 32(36):9810–9817.
14. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL,
Schlager JJ: Unique cellular interaction of silver nanoparticles:
size-dependent generation of reactive oxygen species. J Phys
Chem B 2008, 112(43):13608–13619.
15. Asharani PV, Hande MP, Valiyaveettil S: Anti-proliferative activity of silver
nanoparticles. BMC Cell Biol 2009, 10:65.
16. Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH: A case of generalized
argyria after ingestion of colloidal silver solution. Am J Ind Med 2009,
52(3):246–250.
17. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ: In vitro toxicity of
nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005, 19(7):975–983.
18. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ: The
interaction of manganese nanoparticles with PC-12 cells induces dopamine
depletion. Toxicol Sci 2006, 92(2):456–463.
19. Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH: Cellular
toxicity of various inhalable metal nanoparticles on human alveolar
epithelial cells. Inhal Toxicol 2007, 19:59–65.
Han et al. Nanoscale Research Letters 2014, 9:459 Page 13 of 14
http://www.nanoscalereslett.com/content/9/1/45920. Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager JJ,
Hussain SM, Hofmann MC: Silver nanoparticles disrupt GDNF/Fyn
kinase signaling in spermatogonial stem cells. Toxicol Sci 2010,
116(2):577–589.
21. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY: Oxidative
stress-dependent toxicity of silver nanoparticles in human hepatoma
cells. Toxicol In Vitro 2009, 23(6):1076–1084.
22. Tiwari DK, Jin T, Behari J: Dose-dependent in-vivo toxicity assessment of
silver nanoparticle in Wistar rats. Toxicol Mech Methods 2011, 21(1):13–24.
23. Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD,
Murdock RC, Schlager JJ, Hussain SM, Ali SF: Expression of genes related
to oxidative stress in the mouse brain after exposure to silver-25
nanoparticles. Toxicol Lett 2009, 187(1):15–21.
24. Kawata K, Osawa M, Okabe S: In vitro toxicity of silver nanoparticles at
noncytotoxic doses to HepG2 human hepatoma cells. Environ Science
Tech 2009, 43(15):6046–6051.
25. Stevanovic M, Uskokovic V, Filipovic M, Skapin SD, Uskokovic D: Composite
PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive,
antioxidative, and antimicrobial activities. ACS Appl Mater Interfaces 2013,
5(18):9034–9042.
26. Stevanovic M, Kovacevic B, Petkovic J, Filipic M, Uskokovic D: Effect of
poly-alpha, gamma, L-glutamic acid as a capping agent on morphology
and oxidative stress-dependent toxicity of silver nanoparticles. Int J
Nanomedicine 2011, 6:2837–2847.
27. Filipović N, Stevanović M, Radulović A, Pavlović V, Uskoković D: Facile
synthesis of poly(ε-caprolactone) micro and nanospheres using different
types of polyelectrolytes as stabilizers under ambient and elevated
temperature. Compos Part B 2013, 45(1):1471–1479.
28. Comfort KK, Maurer EI, Braydich-Stolle LK, Hussain SM: Interference of silver,
gold, and iron oxide nanoparticles on epidermal growth factor signal
transduction in epithelial cells. ACS Nano 2011, 5(12):10000–10008.
29. Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D,
Kulthong K, Chanvorachote P, Maniratanachote R: Silver nanoparticles
induce toxicity in A549 cells via ROS-dependent and ROS-independent
pathways. Toxicology In Vitro 2013, 27(1):330–338.
30. Gunzman MG, Dille J, Godet S: Synthesis of silver nanoparticles by
chemical reduction method and their antibacterial activity. World
Academy Sci Eng Tech 2008, 2:329–336.
31. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Park JH, Cho SG, Kim JH:
Green synthesis of anisotropic silver nanoparticles and its potential
cytotoxicity in human breast cancer cells (MCF-7). J Ind Eng Chem 2013,
19(5):1600–1605.
32. Kalishwaralal K, Deepak V, Pandian SRK, Kottaisamy M, BarathmaniKanth S,
Kartikeyan B, Gurunathan S: Biosynthesis of silver and gold nanoparticles
using Brevibacterium casei. Colloid Surface B 2010, 77(2):257–262.
33. Kalimuthu K, Babu RS, Venkataraman D, Bilal M, Gurunathan S: Biosynthesis
of silver nanocrystals by Bacillus licheniformis. Colloid Surface B 2008,
65(1):150–153.
34. Sastry M, Mayya KS, Bandyopadhyay K: pH Dependent changes in the
optical properties of carboxylic acid derivatized silver colloidal
particles. Colloids Surf A: Physicochemical and Engineering Aspects 1997,
127(1–3):221–228.
35. Sastry M, Patil V, Sainkar SR: Electrostatically controlled diffusion of
carboxylic acid derivatized silver colloidal particles in thermally
evaporated fatty amine films. J Phys Chem B 1998, 102(8):1404–1410.
36. Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, Deepak V, Muniyandi J,
Eom SH, Gurunathan S: Silver nanoparticles inhibit VEGF induced
cell proliferation and migration in bovine retinal endothelial cells.
Colloids Surf B: Biointerfaces 2009, 73(1):51–57.
37. Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R,
Eom SH: Antiangiogenic properties of silver nanoparticles. Biomaterials
2009, 30(31):6341–6350.
38. Sriram MI, Kanth SB, Kalishwaralal K, Gurunathan S: Antitumor activity of
silver nanoparticles in Dalton's lymphoma ascites tumor model. Int J
Nanomedicine 2010, 5:753–762.
39. Edetsberger M, Gaubitzer E, Valic E, Waigmann E, Kohler G: Detection of
nanometer-sized particles in living cells using modern fluorescence
fluctuation methods. Biochem Biophysic Res Comm 2005, 332(1):109–116.
40. Liu L, Ni F, Zhang J, Jiang X, Lu X, Guo Z, Xu R: Silver nanocrystals sensitize
magnetic-nanoparticle-mediated thermo-induced killing of cancer cells.
Acta Biochim Biophys Sin (Shanghai) 2011, 43(4):316–323.41. Gole A, Dash C, Ramakrishnan V, Sainkar SR, Mandale AB, Rao M, Sastry M:
Pepsin-gold colloid conjugates: preparation, characterization, and
enzymatic activity. Langmuir 2001, 17(5):1674–1679.
42. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM:
Characterization of nanomaterial dispersion in solution prior to In vitro
exposure using dynamic light scattering technique. Toxicol Sci 2008,
101(2):239–253.
43. Shahverdi AR, Minaeian S, Shahverdi HR, Jamalifar H, Nohi A-A: Rapid
synthesis of silver nanoparticles using culture supernatants of
Enterobacteria: A novel biological approach. Process Biochem 2007,
42(5):919–923.
44. Jain D, Kachhwaha S, Jain R, Srivastava G, Kothari SL: Novel microbial route
to synthesize silver nanoparticles using spore crystal mixture of Bacillus
thuringiensis. Ind J Exp Biology 2010, 48(11):1152–1156.
45. Gurunathan S, Raman J, Abd Malek SN, John PA, Vikineswary S: Green
synthesis of silver nanoparticles using Ganoderma neo-japonicum
Imazeki: a potential cytotoxic agent against breast cancer cells. Int J
Nanomedicine 2013, 8:4399–4413.
46. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya
RH: Silver-protein (core-shell) nanoparticle production using spent
mushroom substrate. Langmuir 2007, 23(13):7113–7117.
47. Bhat R, Deshpande R, Ganachari SV, Huh do S, Venkataraman A:
Photo-irradiated biosynthesis of silver nanoparticles using edible
mushroom pleurotus Florida and their antibacterial activity studies.
Bioinorganic Chem App 2011, 2011:650979.
48. Philip D, Philip D: Biosynthesis of Au, Ag and Au-Ag nanoparticles using
edible mushroom extract. Spectrochim Acta A 2009, 73(2):374–381.
49. Karwa AS, Rai MK: Naturally occurring medicinal mushroom-derived
antimicrobials: a case-study using Lingzhi or Reishi Ganoderma lucidum
(W. Curt.:Fr.) P. Karst. (higher Basidiomycetes). Int J Med Mushrooms 2012,
14(5):481–490.
50. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM:
Research strategies for safety evaluation of nanomaterials. Part VI.
Characterization of nanoscale particles for toxicological evaluation.
Toxicol Sci 2006, 90(2):296–303.
51. Zook JM, Maccuspie RI, Locascio LE, Halter MD, Elliott JT: Stable
nanoparticle aggregates/agglomerates of different sizes and the effect
of their size on hemolytic cytotoxicity. Nanotoxicology 2011, 5(4):517–530.
52. Kim S, Ryu DY: Silver nanoparticle-induced oxidative stress, genotoxicity
and apoptosis in cultured cells and animal tissues. J App Toxicol 2013,
33(2):78–89.
53. Suliman YA, Ali D, Alarifi S, Harrath AH, Mansour L, Alwasel SH: Evaluation
of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of
silver nanoparticles in human lung epithelial cells. Environ Toxicol 2013,
doi:10.1002/tox.21880 [Epub ahead of print].
54. Gurunathan S, Han JW, Eppakayala V, Jeyaraj M, Kim JH: Cytotoxicity of
biologically synthesized silver nanoparticles in MDA-MB-231 human
breast cancer cells. BioMed Res Int 2013, 2013:535796.
55. Mukherjee S, Chowdhury D, Kotcherlakota R, Patra S, Vinothkumar B,
Bhadra MP, Sreedhar B, Patra CR: Potential theranostics application
of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics 2014,
4(3):316–335.
56. Gnanadhas DP, Ben Thomas M, Thomas R, Raichur AM, Chakravortty D:
Interaction of silver nanoparticles with serum proteins affects their
antimicrobial activity in vivo. Antimicrob Agents Chemother 2013,
57(10):4945–4955.
57. Jaiswal S, Duffy B, Jaiswal AK, Stobie N, McHale P: Enhancement of
the antibacterial properties of silver nanoparticles using beta-
cyclodextrin as a capping agent. Int J Antimicrobial Agents 2010,
36(3):280–283.
58. Amato E, Diaz-Fernandez YA, Taglietti A, Pallavicini P, Pasotti L, Cucca L,
Milanese C, Grisoli P, Dacarro C, Fernandez-Hechavarria JM, Necchi V:
Synthesis, characterization and antibacterial activity against gram
positive and gram negative bacteria of biomimetically coated silver
nanoparticles. Langmuir 2011, 27(15):9165–9173.
59. Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging
discipline evolving from studies of ultrafine particles. Environ Health
Perspect 2005, 113(7):823–839.
60. Miura N, Shinohara Y: Cytotoxic effect and apoptosis induction by
silver nanoparticles in HeLa cells. Biochem Biophys Res Commun 2009,
390(3):733–737.
Han et al. Nanoscale Research Letters 2014, 9:459 Page 14 of 14
http://www.nanoscalereslett.com/content/9/1/45961. Kim TH, Kim M, Park HS, Shin US, Gong MS, Kim HW: Size-dependent
cellular toxicity of silver nanoparticles. J Biomed Mater Res Part A 2012,
100(4):1033–1043.
62. Arora S, Jain J, Rajwade JM, Paknikar KM: Cellular responses induced by
silver nanoparticles: In vitro studies. Toxicol Lett 2008, 179(2):93–100.
63. Foldbjerg R, Dang DA, Autrup H: Cytotoxicity and genotoxicity of silver
nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 2011,
85(7):743–750.
64. Franco-Molina MA, Mendoza-Gamboa E, Sierra-Rivera CA, Gómez-Flores RA,
Zapata-Benavides P, Castillo-Tello P, Alcocer-González JM, Miranda-Hernández
DF, Tamez-Guerra RS, Rodríguez-Padilla C: Antitumor activity of colloidal silver
on MCF-7 human breast cancer cells. J Exp Clin Canc Res 2010, 29:148.
65. Zhang D, Zhao YX, Gao YJ, Gao FP, Fan YS, Li XJ, Duan ZY, Wang H:
Anti-bacterial and in vivo tumor treatment by reactive oxygen
species generated by magnetic nanoparticles. J Mater Chem B 2013,
1(38):5100–5107.
66. Minai L, Yeheskely-Hayon D, Yelin D: High levels of reactive oxygen
species in gold nanoparticle-targeted cancer cells following femtosecond
pulse irradiation. Sci Rep 2013, 3:2146.
67. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ: The apoptotic effect
of nanosilver is mediated by a ROS- and JNK-dependent mechanism
involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008,
179(3):130–139.
68. Kimata M, Matoba S, Iwai-Kanai E, Nakamura H, Hoshino A, Nakaoka M,
Katamura M, Okawa Y, Mita Y, Okigaki M, Ikeda K, Tatsumi T, Matsubara H:
p53 and TIGAR regulate cardiac myocyte energy homeostasis under
hypoxic stress. Am J Physiol-Heart C 2010, 299(6):H1908–H1916.
69. Rasola A, Bernardi P: The mitochondrial permeability transition pore
and its involvement in cell death and in disease pathogenesis.
Apoptosis 2007, 12(5):815–833.
70. Han L, Du LB, Kumar A, Jia HY, Liang XJ, Tian Q, Nie GJ, Liu Y:
Inhibitory effects of trolox-encapsulated chitosan nanoparticles on
tert-butylhydroperoxide induced RAW264.7 apoptosis. Biomaterials 2012,
33(33):8517–8528.
71. Mizushima N: Autophagy: process and function. Gene Dev 2007,
21(22):2861–2873.
72. Xie ZP, Klionsky DJ: Autophagosome formation: core machinery and
adaptations. Nat Cell Biol 2007, 9(10):1102–1109.
73. Zhang XS, Banerjee A, Banks WA, Ercal N: N-Acetylcysteine amide protects
against methamphetamine-induced oxidative stress and neurotoxicity in
immortalized human brain endothelial cells. Brain Res 2009, 1275:87–95.
74. Ma Q, Fang HQ, Shang W, Liu L, Xu Z, Ye T, Wang X, Zheng M, Chen Q,
Cheng H: Superoxide flashes: early mitochondrial signals for oxidative
stress-induced apoptosis. J Bio Chem 2011, 286(31):27573–27581.
75. Kiffin R, Bandyopadhyay U, Cuervo AM: Oxidative stress and autophagy.
Antioxid Redox Signal 2006, 8(1–2):152–162.
76. Essick EE, Sam F: Oxidative stress and autophagy in cardiac disease,
neurological disorders, aging and cancer. Oxid Med Cell Longev 2010,
3(3):168–177.
77. Deng XB, Zhang F, Rui W, Long F, Wang L, Feng Z, Chen D, Ding W:
PM2.5-induced oxidative stress triggers autophagy in human lung
epithelial A549 cells. Toxicol In Vitro 2013, 27(6):1762–1770.
78. Benassi B, Fanciulli M, Fiorentino F, Porrello A, Chiorino G, Loda M, Zupi G,
Biroccio A: c-Myc phosphorylation is required for cellular response to
oxidative stress. Mol Cell 2006, 21(4):509–519.
79. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB: Oxidative stress
induces autophagic cell death independent of apoptosis in transformed
and cancer cells. Cell Death Differ 2008, 15(1):171–182.
doi:10.1186/1556-276X-9-459
Cite this article as: Han et al.: Oxidative stress mediated cytotoxicity of
biologically synthesized silver nanoparticles in human lung epithelial
adenocarcinoma cell line. Nanoscale Research Letters 2014 9:459.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
